세계의 POC(Point-of-Care) 진단 시장 보고서(2025년)
Point of Care Diagnostics Global Market Report 2025
상품코드 : 1821696
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,546,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,462,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,378,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

POC(Point-of-Care) 진단 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR)은 9.4%를 나타내 738억 6,000만 달러로 성장할 전망입니다. 예측 기간 성장의 배경으로는 원격지에서의 헬스케어 요구, 신흥경제국에서 시장개척, 개인화 헬스케어, 예방헬스케어에 대한 주력, 연구개발에 대한 투자가 있습니다. 예측 기간의 주요 동향으로는 맞춤형 의료의 시작, 기술의 소형화, 원격 의료 통합, 신규 바이오 마커의 출현, 소비자의 강화 등이 있습니다.

향후 5년간의 성장률 9.4%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과로 인해 일본과 스위스에서 수입되는 신속한 혈액 분석기나 바이오마커 검사용 카트리지에 대한 접근이 제한되어 적시의 의사결정이 손상되어 1차 케어의 검사 비용이 증가할 수 있기 때문에 미국의 진료소에 있어서 큰 과제가 될 수 있습니다. 또한 상호관세와 무역마찰과 무역제한의 격화에 의한 세계경제와 무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 보입니다.

만성 질환과 감염의 이환율 증가는 POC(Point-of-Care) 진단 시장을 촉진하고 있습니다. 만성 질환은 시간이 지남에 따라 점차 발병하며 보통 3개월 이상 지속되는 질환입니다. POC 진단은 만성 질환의 효과적인 관리에 중요한 역할을 하며, 편의성에서 널리 이용되고 있습니다. 예를 들어, 2023년 미국 질병 예방관리센터(CDC)는 성인의 42%가 2개 이상의 만성 질환을 갖고 살고 있다고 보고했습니다. 이 동향은 성인 인구간에 복수의 만성 질환의 유병률이 높아지고 있는 것을 부조로 하고 있어 우려를 안겨줍니다. 그 결과 만성 질환의 만연이 POC(Point-of-Care) 진단 시장 확대를 뒷받침하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Point of care (POC) diagnostics involves medical testing conducted at or near the location of patient care, providing fast and accurate results to guide immediate patient care decisions.

The primary product types in point of care diagnostics include glucose monitoring kits, infectious diseases testing kits, pregnancy and fertility testing kits, hematology testing kits, cardiometabolic monitoring kits, urinalysis testing kits, cholesterol test strips, and others. Glucose monitoring kits are medical devices designed to measure the levels of glucose (sugar) in a person's blood. They are available as both over-the-counter (OTC) devices and prescription-based devices, catering to various end-users such as professional diagnostic centers, research laboratories, home care settings, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The point of care diagnostics market research report is one of a series of new reports from The Business Research Company that provides point of care diagnostics optical components market statistics, including point of care diagnostics optical components industry global market size, regional shares, competitors with a point of care diagnostics optical components market share, detailed point of care diagnostics optical components market segments, market trends and opportunities, and any further data you may need to thrive in the point of care diagnostics optical components industry. This point of care diagnostics optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point of care diagnostics market size has grown strongly in recent years. It will grow from $48.06 billion in 2024 to $51.62 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rise of chronic diseases, diagnostic accuracy improvements, shift in healthcare setting, healthcare cost pressures, consumer demand for convenience.

The point of care diagnostics market size is expected to see strong growth in the next few years. It will grow to $73.86 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to remote healthcare needs, market expansion in emerging economies, personalized healthcare, focus on preventive healthcare, investment in research & development. Major trends in the forecast period include rise of personalized medicine, technological miniaturization, telemedicine integration, emergence of novel biomarkers, consumer empowerment.

The forecast of 9.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. clinics by restricting access to rapid blood analyzers and biomarker test cartridges imported from Japan and Switzerland, potentially compromising timely decision-making and increasing primary care testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of chronic and infectious diseases is propelling the point-of-care (POC) diagnostics market. Chronic diseases are conditions that develop gradually over time and typically last three months or longer. POC diagnostics play a crucial role in the effective management of chronic diseases and are widely utilized due to their convenience. For example, in 2023, the Centers for Disease Control and Prevention (CDC) reported that 42% of adults in the U.S. were living with two or more chronic conditions. This trend raises concerns as it underscores the increasing prevalence of multiple chronic diseases among the adult population. Consequently, the growing prevalence of chronic diseases is driving the expansion of the point-of-care (POC) diagnostics market.

The point-of-care (POC) diagnostics market is set to experience growth propelled by the rising demand for at-home testing. At-home testing involves self-sample collection and testing using over-the-counter or online kits/devices. Point-of-care (POC) diagnostics play a pivotal role in at-home testing, allowing individuals to conveniently monitor their health status. A survey conducted in December 2022 revealed that approximately 25% of consumers demand at-home testing, with 21% finding it convenient. This increasing preference for at-home testing is a significant contributor to the expanding point-of-care (POC) diagnostics market.

Innovation is a prominent trend in the point-of-care (POC) diagnostics market, with major companies introducing novel products to maintain their market position. For instance, PocDoc, a US-based diagnostics company, launched the PocDoc Cardiovascular Diseases point-of-care test in January 2022. This innovative product stands out as the world's first smartphone-based test for cardiovascular disease, offering users a five-step process, including sample collection, lateral flow test kit usage, and instant diagnosis on their smartphones.

Key players in the point-of-care (POC) diagnostics market are concentrating on technological innovations, such as rapid PCR systems, to secure a competitive advantage. A rapid PCR system is a type of polymerase chain reaction (PCR) test that delivers results faster than traditional PCR tests. For example, in January 2023, Cipla, a pharmaceutical company based in India, introduced its point-of-care testing device named Cippoint. This innovative device is designed to provide quick and accurate diagnostic results for a variety of health conditions. The Cippoint platform is compact, user-friendly, and adaptable for use in various settings, including hospitals and clinics. It utilizes advanced technology that allows healthcare professionals to conduct tests efficiently and effectively.

In July 2024, Roche, a pharmaceutical company based in Switzerland, acquired LumiraDx's point-of-care technology for an undisclosed sum. This strategic acquisition is intended to improve Roche's access to diagnostic testing in primary care environments. LumiraDx, a company located in the U.S., specializes in innovative point-of-care diagnostic solutions.

Major companies operating in the point of care diagnostics market include Abbott Laboratories, Siemens Healthineers AG, Beckman Coulter Inc., Becton, Dickinson and Company, Instrumentation Laboratory Company, Nova Biomedical Corporation, Qiagen NV, F. Hoffmann-La Roche Ltd., Biomeriux SA, Quidel Corporation, Orasure Technologies Inc., Johnson and Johnson, Thermo Fisher Scientific Inc., Sysmex corporation, Sinocare Inc., Arkray Inc., Danaher Corporation, Chembio Diagnostics Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Fluxergy Inc., LumiraDx UK Ltd., Meridian Bioscience Inc., Nipro Europe Group Companies, AccuBioTech Co. Ltd., Atlas Genetics Ltd., Atlas Link Biotech Co. Ltd., Biomeme Inc., Cepheid Inc., Church & Dwight Co. Inc.

North America was the largest region in the point of care diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the point of care diagnostics market report during the forecast period. The regions covered in the point of care diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the point of care diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point of care (POC) diagnostics market consists of sales of blood glucose meters, pregnancy test kits, and cardiac markers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point of Care Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point of care diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for point of care diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Point of Care Diagnostics Market Characteristics

3. Point of Care Diagnostics Market Trends And Strategies

4. Point of Care Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Point of Care Diagnostics Growth Analysis And Strategic Analysis Framework

6. Point of Care Diagnostics Market Segmentation

7. Point of Care Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Point of Care Diagnostics Market

9. China Point of Care Diagnostics Market

10. India Point of Care Diagnostics Market

11. Japan Point of Care Diagnostics Market

12. Australia Point of Care Diagnostics Market

13. Indonesia Point of Care Diagnostics Market

14. South Korea Point of Care Diagnostics Market

15. Western Europe Point of Care Diagnostics Market

16. UK Point of Care Diagnostics Market

17. Germany Point of Care Diagnostics Market

18. France Point of Care Diagnostics Market

19. Italy Point of Care Diagnostics Market

20. Spain Point of Care Diagnostics Market

21. Eastern Europe Point of Care Diagnostics Market

22. Russia Point of Care Diagnostics Market

23. North America Point of Care Diagnostics Market

24. USA Point of Care Diagnostics Market

25. Canada Point of Care Diagnostics Market

26. South America Point of Care Diagnostics Market

27. Brazil Point of Care Diagnostics Market

28. Middle East Point of Care Diagnostics Market

29. Africa Point of Care Diagnostics Market

30. Point of Care Diagnostics Market Competitive Landscape And Company Profiles

31. Point of Care Diagnostics Market Other Major And Innovative Companies

32. Global Point of Care Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point of Care Diagnostics Market

34. Recent Developments In The Point of Care Diagnostics Market

35. Point of Care Diagnostics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기